Uniquely placed at the center of Boston metro biotech clusters and academia, Mass General Neuroscience transforms patient care through translational and basic research. Below are just some the research programs that we have to offer.
We are devoted to the development and application of advanced biomedical imaging technologies.
We work to complete the genomic medicine cycle by assessing where genomic medicine will have the greatest impact on human health.
We unite scientists and physician-scientists to translate laboratory findings into the clinic where they can reach patients.
We are on a quest to discover lifesaving therapies for those who are affected by amyotrophic lateral sclerosis.
We design clinical neurotechnologies and performs high resolution neurophysiology research.
Read the latest research coming from our research programs and laboratories from Mass General Neuroscience.
Marijuana and the Young Brain
Jodi Gilman, PhD, is the director of neuroscience at the Center for Addiction Medicine. Her research examines how marijuana affects the teen brain.
Using Immunotherapy to Treat Brain Tumors
William Curry, MD, co-director of Neuroscience and director of Neurosurgical Oncology, is optimistic about treating patients with brain tumors. In this video, he discusses the potential of using a personalized approach to vaccinating patients with their own tumor cells.
Prenatal Folic Acid and Schizophrenia Prevention
Joshua Roffman, MD, discusses his recent work investigating folic acid’s neuroprotective effects that may guard against schizophrenia development.
Research Advances From Mass General Neurology
Researchers from the Department of Neurology at Massachusetts General Hospital discuss their collaborative and individual work in clinical and translational research.
Advances in Epilepsy Surgery
Ziv Williams, MD, neurosurgeon at Massachusetts General Hospital, describes the advances in epilepsy surgery, which involve the use of responsive neural stimulators and thermal laser ablation.
New Therapies for Brain Tumors
Brain tumors are difficult to treat because the brain has natural barriers that can resist therapy. In this video, Bakhos A. Tannous, PhD, director of the Experimental Therapeutics and Molecular Imaging Lab, his research in treating brain tumors more efficiently.
New Ways to Treat Patients with Large Vessel Occlusions
Thabele M. Leslie-Mazwi, MD, focuses on developing treatments for a subset of ischemic stroke called large vessel occlusion stroke.
NIH Neuroscience Funding at Mass General
Nearly one-third of Mass General's NIH funding goes towards neuroscience-based research.
#1 Research Hospital in America
Mass General is the #1 research hospital in America, with a large percentage of that dedicated to nervous system related disorders.
Massachusetts Biotech Ecosystem
Worlds largest concentration of biotechnology and research centers.
Visit some of the other programs that Mass General Neuroscience has to offer:
- The Multicultural Alzheimer’s Prevention Program (MAPP) is an initiative to advance the understanding of Alzheimer’s disease and related dementias and prevent cognitive decline through culturally informed interventions
- The Clay Center for Young Healthy Minds is a free online educational resource dedicated to promoting and supporting the well-being of children, teens, and young adults
- The Clinical Trials Network & Institute ensures that our innovative research methods are unmatched in helping sponsors meet their research goals
Mass General Neuroscience has over 1,000 neuroscience faculty members from across all hospital departments at the hospital. Below are a few of our faculty members. You can also search for our faculty on Find a Researcher.